COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1021: Articles 10201-10210  | Next

SARS-CoV-2 triggers complement activation through interactions with heparan sulfate
Lo, M. W., Amarilla, A. A., Lee, J. D., Albornoz, E. A., Modhiran, N., Clark, R. J., Ferro, V., Chhabra, M., Khromykh, A. A., Watterson, D., Woodruff, T. M.
10.1101/2022.01.11.475820 — Posted: 2022-01-11
A single-cell atlas reveals shared and distinct immune responses and metabolism during SARS-CoV-2 and HIV-1 infections
Pan, T., Cao, G., Tang, E., Zhao, Y., Penaloza-MacMaster, P., Fang, Y., Huang, J.
10.1101/2022.01.10.475725 — Posted: 2022-01-11
The impact of post-hospital remote monitoring of COVID-19 patients using pulse oximetry: a national observational study using hospital activity data
Georghiou, T., Sherlaw-Johnson, C., Massou, E., Morris, S., Crellin, N. E., Herlitz, L., Sidhu, M. S., Tomini, S. M., Vindrola-Padros, C., Walton, H., Fulop, N. J.
10.1101/2022.01.11.22269068 — Posted: 2022-01-11
The incidence and mortality of COVID-19 related TB infection in Sub-Saharan Africa: A systematic review and meta-analysis
Tamuzi, J. J., Lulendo, G., Mbuesse, P.
10.1101/2022.01.11.22269065 — Posted: 2022-01-11
COVID-19 vaccination breakthrough infections in a real-world setting: Using community reporters to evaluate vaccine effectiveness
Reynolds, M. W., Xie, Y., Knuth, K. B., Mack, C. D., Brinkley, E., Toovey, S., Dreyer, N. A.
10.1101/2022.01.11.22268736 — Posted: 2022-01-11
Systematic review and meta-analysis of COVID-19 vaccines safety, tolerability, and efficacy among HIV-infected patients
Tamuzi, J. J., Muyaya, L. M., Mitra, A., Nyasulu, P.
10.1101/2022.01.11.22269049 — Posted: 2022-01-11
Plasma SARS-CoV-2 RNA levels as a biomarker of lower respiratory tract SARS-CoV-2 infection in critically ill patients with COVID-19.
Jacobs, J., Naqvi, A., Shah, F., Boltz, V., Kearney, M., McVerry, B., Ray, P., Schaefer, C., Fitzpatrick, M., Methe, B., Lee, J., Morris, A., Mellors, J., Kitsios, G., Bain, W.
10.1101/2022.01.10.22269018 — Posted: 2022-01-11
Impact of COVID-19 Pandemic on Utilization of Facility-Based Essential Maternal and Child Health Services in North Shewa Zone, Ethiopia
Bekele, C., Bekele, D., Hunegnaw, B., Van Wickle, K., Ashenafi, F., Korte, M., Tedijanto, C., Tadesse, L., Chan, G.
10.1101/2022.01.10.22268794 — Posted: 2022-01-11
Covid-19 disease dynamics with vaccination: The effect of uncertainty
Bairagi, N., Majumder, A.
10.1101/2022.01.10.22269006 — Posted: 2022-01-11
Cohort-specific serological recognition of SARS-CoV-2 variant RBD antigens
Fraser, D. D., Miller, M. R., Martin, C. M., Slessarev, M., Hahn, P., Higgins, I., Melo, C., Pest, M. A., Rothery, N., Wang, X., Zeidler, J., Cruz-Aguado, J. A.
10.1101/2022.01.10.21268250 — Posted: 2022-01-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).